![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
2 Ann Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Response to letters to the Editor on 'Abemaciclib plus a nonsteroidal aromatase
inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall
survival results of MONARCH 3'.
Ann Oncol. 2024;35:1202-1204.
PubMed
Corrigendum to "Understanding breast cancer complexity to improve patient
outcomes: The St Gallen International Consensus Conference for the Primary
Therapy of Individuals with Early Breast Cancer 2023": [Annals of Oncology 34
(2023) 970-986].
Ann Oncol. 2024 Dec 2:S0923-7534(24)04882-8. doi: 10.1016/j.annonc.2024.
PubMed
ASO Visual Abstract: Impact of Mainstream Germline Genetic Testing with Expanded
Eligibility for Early Stage Breast Cancer Patients in a Large Integrated Health
System.
Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16559.
PubMed
Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the
COVID-19 Pandemic: A Real-World Cohort Study.
Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16645.
PubMed
Abstract available
Risk of Surgical Overtreatment in cN1 Breast Cancer Patients who Become ypN0
After Neoadjuvant Chemotherapy: SLNB Versus TAD.
Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16625.
PubMed
Abstract available
ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response
to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer.
Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16606.
PubMed
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients
Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the
NEOSENTITURK-Trials MF18-02/18-03.
Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16472.
PubMed
Abstract available
Comprehensive Analysis of GJB1 in Breast Cancer: Its Implications in Survival and
Molecular Mechanisms.
Anticancer Res. 2024;44:5379-5391.
PubMed
Abstract available
Exposure to Hypoxic Conditions Up-regulates HER2 in Breast Cancer Cell Lines.
Anticancer Res. 2024;44:5187-5192.
PubMed
Abstract available
Impact of Warm Ischemia Time on HER2 Expression in Breast Cancer Surgical
Specimens.
Anticancer Res. 2024;44:5225-5230.
PubMed
Abstract available
Patterns of breast cancer locoregional relapse, metastasis, and subtypes in
Ghana.
BMC Cancer. 2024;24:1485.
PubMed
Abstract available
Advances in breast cancer and bowel cancer treatments ... and other research.
BMJ. 2024;387:q2699.
PubMed
A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on
3776 Japanese patients.
Breast Cancer. 2024 Dec 4. doi: 10.1007/s12282-024-01656.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Efficacy and Survival Analysis of Radiotherapy for Internal Mammary Lymph Nodes
After Modified Radical Mastectomy for T(1-3)N(3)M(0) the Lateral Quadrant Breast
Cancer.
Breast Cancer (Dove Med Press). 2024;16:811-823.
PubMed
Abstract available
Identification and Validation of circDOCK1/miR-138-5p/GRB7 Axis for Promoting
Breast Cancer Progression.
Breast Cancer (Dove Med Press). 2024;16:795-810.
PubMed
Abstract available
Dysregulation of Fatty Acid Metabolism in Breast Cancer and Its Targeted Therapy.
Breast Cancer (Dove Med Press). 2024;16:825-844.
PubMed
Abstract available
Feasibility Study of Pyrrolitinib-Based Dual-Target Therapy for Neoadjuvant
Treatment of HER2-Positive Breast Cancer Patients.
Breast Cancer (Dove Med Press). 2024;16:845-853.
PubMed
Abstract available
NF-kappaB associated markers of prognosis in early and metastatic triple negative
breast cancer.
Breast Cancer Res. 2024;26:175.
PubMed
Abstract available
Social vulnerability is associated with advanced breast cancer presentation and
all-cause mortality: a retrospective cohort study.
Breast Cancer Res. 2024;26:176.
PubMed
Abstract available
Multimodal genome-wide survey of progressing and non-progressing breast ductal
carcinoma in-situ.
Breast Cancer Res. 2024;26:178.
PubMed
Abstract available
Image analysis-based identification of high risk ER-positive, HER2-negative
breast cancers.
Breast Cancer Res. 2024;26:177.
PubMed
Abstract available
Alcohol cessation and breast cancer risk stratified by hormone receptor status.
Breast Cancer Res. 2024;26:179.
PubMed
Abstract available
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2
trial for early breast cancer.
Breast Cancer Res Treat. 2024 Dec 3. doi: 10.1007/s10549-024-07555.
PubMed
Abstract available
Incidence, treatment patterns, and mortality for patients with breast cancer
during the first year of the COVID-19 pandemic: a population-based study.
Breast Cancer Res Treat. 2024 Dec 2. doi: 10.1007/s10549-024-07562.
PubMed
Abstract available
The role of body composition in neurological and hematologic toxicity in a
retrospective analysis of 120 breast cancer patients undergoing neoadjuvant
chemotherapy: the COMBOTOX study.
Breast Cancer Res Treat. 2024 Dec 4. doi: 10.1007/s10549-024-07553.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Evaluation of multiple breast cancer polygenic risk score panels in women of
Latin American heritage.
Cancer Epidemiol Biomarkers Prev. 2024 Dec 3. doi: 10.1158/1055-9965.EPI-24-1247
PubMed
Abstract available
The Untapped Opportunities of Addressing Lifecourse Growth in Mammographic Breast
Density and Breast Cancer Prevention in Non-Hispanic Black Women.
Cancer Epidemiol Biomarkers Prev. 2024;33:1541-1543.
PubMed
Abstract available
The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma
In Situ of the Breast.
Cancer Epidemiol Biomarkers Prev. 2024;33:1633-1639.
PubMed
Abstract available
Lifecourse Growth and Development Determinants of Mammographic Density in Black
Women.
Cancer Epidemiol Biomarkers Prev. 2024;33:1640-1650.
PubMed
Abstract available
Tales of Cancer-Induced Bone Disease from the Senescent Osteocyte Crypt.
Cancer Res. 2024;84:3917-3918.
PubMed
Abstract available
Metronomic Chemotherapy in Breast Cancer as a Strategy to Deliver More
Sustainable and Less Toxic Treatments: Time to Debunk the Myth?
Clin Breast Cancer. 2024 Nov 12:S1526-8209(24)00301.
PubMed
Abstract available
Madarosis Among Breast Cancer Survivors: Correspondence.
Clin Breast Cancer. 2024 Nov 8:S1526-8209(24)00298.
PubMed
High Expression of ZNF208 Predicts Better Prognosis and Suppresses the
Tumorigenesis of Breast Cancer.
Clin Med Insights Oncol. 2024;18:11795549241301341.
PubMed
Abstract available
Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond
Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative
Advanced Breast Cancer - A Clinical Review.
Curr Treat Options Oncol. 2024 Nov 30. doi: 10.1007/s11864-024-01259.
PubMed
Abstract available
Feasibility of breast conserving surgery alone in HER2-positive exceptional
responders to neoadjuvant systemic therapy.
Eur J Surg Oncol. 2024;50:108613.
PubMed
Abstract available
Timeline of surgery in localized angiosarcoma of the breast: Improving outcome
following multidisciplinary treatment optimization.
Eur J Surg Oncol. 2024;50:108699.
PubMed
Abstract available
Long non-coding RNAs and their role in breast cancer pathogenesis and drug
resistance: Navigating the non-coding landscape review.
Exp Cell Res. 2024;444:114365.
PubMed
Abstract available
Investigation and validation of neurotransmitter receptor-related biomarkers for
forecasting clinical outcomes and immunotherapeutic efficacy in breast cancer.
Gene. 2024;937:149135.
PubMed
Abstract available
Clinicopathological characteristics of Japanese patients with breast cancer and
MET exon 14 skipping alterations.
Histopathology. 2024 Dec 4. doi: 10.1111/his.15382.
PubMed
Abstract available
Extensive epigenomic dysregulation is a hallmark of homologous recombination
deficiency in triple-negative breast cancer.
Int J Cancer. 2024 Dec 5. doi: 10.1002/ijc.35274.
PubMed
Abstract available
MicroRNAs and their role in breast cancer metabolism (Review).
Int J Oncol. 2025;66:7.
PubMed
Abstract available
PKC-mediated phosphorylation governs the stability and function of CELF1 as a
driver of EMT in breast epithelial cells.
J Biol Chem. 2024;300:107826.
PubMed
Abstract available
Development and Validation of the RSClinN+ Tool to Predict Prognosis and
Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.
J Clin Oncol. 2024 Dec 2:JCO2401507. doi: 10.1200/JCO-24-01507.
PubMed
Abstract available
[(18)F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [(18)F]FDG PET,
Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status.
J Nucl Med. 2024 Dec 5:jnumed.124.267627. doi: 10.2967/jnumed.124.267627.
PubMed
Abstract available
Plastic surgery market share of breast reconstructive procedures: An analysis of
two nationwide databases.
J Surg Oncol. 2023;128:1064-1071.
PubMed
Abstract available
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced
breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2,
multicentre, open-label, non-comparative study.
Lancet Oncol. 2024;25:e629-e638.
PubMed
Abstract available
Why breast cancer treatments might work best just after your period.
Nature. 2024 Dec 4. doi: 10.1038/d41586-024-03986.
PubMed
What is the best time of the month to treat breast cancer?
Nature. 2024 Dec 4. doi: 10.1038/d41586-024-03847.
PubMed
Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche
formation and promotes lung metastasis.
Oncogene. 2024 Dec 4. doi: 10.1038/s41388-024-03237.
PubMed
Abstract available
A latent class assessment of healthcare access factors and disparities in breast
cancer care timeliness.
PLoS Med. 2024;21:e1004500.
PubMed
Abstract available
Awareness and its determinant factors towards breast examination to detect breast
cancer among reproductive age women in Kenya: Multi level analysis of the recent
demographic and health survey data.
PLoS One. 2024;19:e0314700.
PubMed
Abstract available
Ultrasonographic and pathological correlation of asymmetric retroareolar density
on mammogram.
PLoS One. 2024;19:e0301180.
PubMed
Abstract available
Investigating the relationship between insulin use and all-cause mortality,
breast cancer mortality, and recurrence risk in diabetic patients with breast
cancer: A comprehensive systematic review and meta-analysis.
PLoS One. 2024;19:e0314565.
PubMed
Abstract available
Correction: BCR-Net: A deep learning framework to predict breast cancer
recurrence from histopathology images.
PLoS One. 2024;19:e0315419.
PubMed
Abstract available
An interpretable framework for inter-observer agreement measurements in TILs
scoring on histopathological breast images: A proof-of-principle study.
PLoS One. 2024;19:e0314450.
PubMed
Abstract available
Diagnostic performance of DCE-MRI radiomics in predicting axillary lymph node
metastasis in breast cancer patients: A meta-analysis.
PLoS One. 2024;19:e0314653.
PubMed
Abstract available
miR-379-5p affects breast cancer cell behavior by targeting UBE2E3 ubiquitin
conjugating enzyme.
PLoS One. 2024;19:e0310315.
PubMed
Abstract available
Simultaneous visualization of membrane fluidity and morphology defines adhesion
signatures of cancer cells.
Proc Natl Acad Sci U S A. 2024;121:e2412914121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.